These are all known factors that can enhance T cell‐mediated anti‐tumor immunity as Cxcl9 and Ccl5 are chemoattractive to T cells, and IL‐12 is a potent activator of CD8 T cell effector functions. This evidence concerns the gene CCL5 and neoplasm.